Wed, Jul 23, 2014, 7:37 AM EDT - U.S. Markets open in 1 hr 53 mins


% | $
Click the to save as a favorite.

Questcor Pharmaceuticals, Inc. (QCOR) Message Board

  • pharmaman58 pharmaman58 Jul 11, 2013 5:54 PM Flag


    1. By my analysis, sarcoidosis is another indication showing promise of 300-400 scripts per quarter at 4-6 vials per script. Also opens up the pulmonologist market, who are similar to rheumatologists in that they can prescribe for a number of autoimmune/inflammatory disorders--and all will be 4-6 vial scripts in my opinion.
    2. Rheumatology related scripts living up to their potential.
    3. Analysts starting to raise target prices $5 to $8.
    4. Sounds like a strong Q2 to me, leading into a knockout 2H.

    The spike today was a bit disappointing given the level and immediacy of the news. But give it time and get rewarded. If we know anything about QCOR, it is this: immediate gratification is an elusive commodity.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
95.00+0.25(+0.26%)Jul 22 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.